Oct 16, 2026 07:00AM
Oct 16, 2026 07:00AM
Oct 12, 2026 12:07PM
Oct 12, 2026 12:06PM
Oct 8, 2026 05:20AM
Oct 6, 2026 07:00AM
Oct 1, 2026 11:38AM Regeneron reports 73% response rate for ubamatamab in ovarian cancer
Oct 1, 2026 11:35AM
Oct 1, 2026 07:02AM
Aug 19, 2026 01:58PM
Aug 19, 2026 01:58PM
Jun 29, 2026 04:20PM
Jun 26, 2026 07:00AM
Jun 22, 2026 07:00AM Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
May 28, 2026 04:01PM
May 28, 2026 04:00PM
May 22, 2026 07:01AM
May 22, 2026 07:00AM
May 21, 2026 05:02PM
May 21, 2026 05:01PM
May 18, 2026 03:46PM Regeneron Pharma (REGN) PT Lowered to $860 at Wolfe Research
May 5, 2026 07:01AM
May 5, 2026 07:00AM
Apr 30, 2026 02:49PM
Apr 29, 2026 04:21PM
Apr 29, 2026 06:30AM
Apr 23, 2026 03:46PM
Apr 23, 2026 03:46PM Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.
Apr 23, 2026 12:53PM
Apr 23, 2026 12:40PM
Apr 22, 2026 05:30PM
Apr 22, 2026 05:30PM
Apr 21, 2026 10:30AM
Apr 21, 2026 10:30AM
Apr 13, 2026 01:00AM Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
Apr 8, 2026 08:00AM
Apr 2, 2026 12:01PM
Apr 2, 2026 12:00PM
Mar 24, 2026 04:19AM
Mar 24, 2026 02:00AM
Mar 10, 2026 09:29PM
Mar 6, 2026 02:51AM Barclays Starts Regeneron Pharma (REGN) at Overweight
Mar 3, 2026 05:31PM
Feb 27, 2026 07:13AM
Feb 27, 2026 07:00AM
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM
Feb 19, 2026 07:00AM FDA accepts Regeneron's garetosmab application for priority review
Feb 19, 2026 07:00AM

334,267 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All